Cargando…

Efficacy and Safety of Tocilizumab Treatment COVID-19 Patients: A Case-Control Study and Meta-Analysis

INTRODUCTION: As the pandemic progresses, the pathophysiology of COVID-19 is becoming more apparent, and the potential for tocilizumab is increasing. However, the clinical efficacy and safety of tocilizumab in the treatment of COVID-19 patients remain unclear. METHODS: To assess the efficacy and saf...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Weijun, Li, Weiwei, Wu, Qiuyue, Han, Ying, Zhang, Jing, Luo, Tao, Guo, Yanju, Yang, Yang, Zhu, Peiran, Xia, Xinyi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8269405/ https://www.ncbi.nlm.nih.gov/pubmed/34244956 http://dx.doi.org/10.1007/s40121-021-00483-x

Ejemplares similares

Clinical efficacy of convalescent plasma therapy on treating COVID‐19 patients: Evidence from matched study and a meta‐analysis
por: Jiang, Weijun, et al.
Publicado: (2020)

Upregulated IL-6 Indicates a Poor COVID-19 Prognosis: A Call for Tocilizumab and Convalescent Plasma Treatment
por: Wu, Jian, et al.
Publicado: (2021)

Potential False-Positive and False-Negative Results for COVID-19 IgG/IgM Antibody Testing After Heat-Inactivation
por: Lin, Jie, et al.
Publicado: (2021)

Predictive value of GGN and CAG repeat polymorphisms of androgen receptors in testicular cancer: a meta-analysis
por: Jiang, Weijun, et al.
Publicado: (2016)

The paradoxical problem with COVID-19 ocular infection: Moderate clinical manifestation and potential infection risk
por: Shen, Jiawei, et al.
Publicado: (2021)

The susceptibility of FSHB -211G > T and FSHR G-29A, 919A > G, 2039A > G polymorphisms to men infertility: an association study and meta-analysis
por: Wu, Qiuyue, et al.
Publicado: (2017)

Efficacy and safety of tocilizumab in COVID-19 patients
por: Zheng, Kai-Lian, et al.
Publicado: (2020)

Polymorphisms of protamine genes contribute to male infertility susceptibility in the Chinese Han population
por: Jiang, Weijun, et al.
Publicado: (2017)

Efficacy and safety of tocilizumab in hospitalized COVID-19 patients: A systematic review and meta-analysis
por: Luo, Lili, et al.
Publicado: (2022)

Safety and Efficacy of Tocilizumab for the Treatment of Rheumatoid Arthritis
por: Ogata, Atsushi, et al.
Publicado: (2012)

Polymorphisms in Protamine 1 and Protamine 2 predict the risk of male infertility: a meta-analysis
por: Jiang, Weijun, et al.
Publicado: (2015)

Efficacy and safety of tocilizumab in Korean patients with active rheumatoid arthritis
por: Baek, Han Joo, et al.
Publicado: (2019)

Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis
por: Tleyjeh, Imad M., et al.
Publicado: (2021)

Tumor biomarkers predict clinical outcome of COVID-19 patients
por: He, Bangshun, et al.
Publicado: (2020)

The efficacy and safety of Tocilizumab in adults with refractory systemic onset JIA
por: Deslypere, G, et al.
Publicado: (2011)

Tocilizumab: A Review of Its Safety and Efficacy in Rheumatoid Arthritis
por: Jones, Graeme, et al.
Publicado: (2010)

Safety and efficacy of tocilizumab in children with systemic juvenile idiopathic arthritis
por: Horneff, G, et al.
Publicado: (2015)

Safety and efficacy of tocilizumab for rheumatoid arthritis: a systematic review and meta-analysis of clinical trial studies
por: Saki, Amal, et al.
Publicado: (2021)

Efficacy and safety of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional DMARDs in patients with RA at week 97 (SUMMACTA)
por: Burmester, Gerd R, et al.
Publicado: (2016)

Hyperhomocysteinaemia in rats is associated with erectile dysfunction by impairing endothelial nitric oxide synthase activity
por: Jiang, Weijun, et al.
Publicado: (2016)

Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis – Author’s reply
por: Kashour, Tarek, et al.
Publicado: (2021)

Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis, first update
por: Tleyjeh, Imad M., et al.
Publicado: (2021)

Cardiovascular safety of tocilizumab: A systematic review and network meta-analysis
por: Castagné, Benjamin, et al.
Publicado: (2019)

Safety and efficacy of tocilizumab treatment in children with systemic onset of juvenile idiopathic arthritis
por: Alexeeva, E, et al.
Publicado: (2011)

Efficacy and safety of tocilizumab in european children with systemic onset juvenile idiopathic arthritis
por: Nemiche, O, et al.
Publicado: (2011)

Comparing efficacy and safety of tocilizumab and methylprednisolone in the treatment of patients with severe COVID-19
por: Abbasian, Ladan, et al.
Publicado: (2022)

Integrated safety in tocilizumab clinical trials
por: Schiff, Michael H, et al.
Publicado: (2011)

Efficacy and safety of baricitinib and tocilizumab in hospitalized patients with COVID-19: A comparison using systematic review and meta-analysis
por: Cherian, Jerin Jose, et al.
Publicado: (2022)

Tocilizumab as monotherapy or combination therapy for treating active rheumatoid arthritis: a meta-analysis of efficacy and safety reported in randomized controlled trials
por: Teitsma, Xavier M., et al.
Publicado: (2016)

Clinical efficacy of tocilizumab treatment in severe and critical COVID-19 patients
por: Zeng, Jia, et al.
Publicado: (2020)

Effects of Tocilizumab on Adults With COVID-19 Pneumonia: A Meta-Analysis
por: Chen, Chi-Chung, et al.
Publicado: (2022)

Characteristics of lymphocyte subset alterations in COVID-19 patients with different levels of disease severity
por: Dai, Wei, et al.
Publicado: (2022)

Long-term efficacy and safety of tocilizumab in giant cell arteritis and large vessel vasculitis
por: Evans, Jobie, et al.
Publicado: (2016)

Efficacy of the early treatment with tocilizumab-hydroxychloroquine and tocilizumab-remdesivir in severe COVID-19 Patients
por: Sarhan, Rania M., et al.
Publicado: (2022)

Re: ‘Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis’ by Tleyjeh et al.
por: Koeckerling, David, et al.
Publicado: (2021)

Efficacy and Safety of Eldecalcitol for Osteoporosis: A Meta-Analysis of Randomized Controlled Trials
por: Liu, Hongyan, et al.
Publicado: (2022)

Clinical efficacy and safety of interleukin-6 receptor antagonists (tocilizumab and sarilumab) in patients with COVID-19: a systematic review and meta-analysis
por: Yu, Su-Yeon, et al.
Publicado: (2022)

Case Report: Safety and Efficacy of Tocilizumab in a Patient with Rheumatoid Arthritis and Chronic Hepatitis C
por: Iebba, Filippo, et al.
Publicado: (2012)

Tocilizumab in refractory rheumatoid arthritis: long-term efficacy, safety, and tolerability beyond 2 years
por: Farah, Ziad, et al.
Publicado: (2016)

Efficacy and Safety of Tocilizumab in the Treatment of Acute Active Antibody-mediated Rejection in Kidney Transplant Recipients
por: Pottebaum, April A., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ucshin0rm6bba1krnu1qs72eoh